Thesis Abstract

**Abstract
** Cancer remains a significant health challenge worldwide, necessitating continuous advancements in treatment strategies. This thesis focuses on the development of novel drug delivery systems for targeted cancer therapy, aiming to enhance treatment efficacy while minimizing adverse effects. The research involves the design and evaluation of innovative drug carriers capable of delivering therapeutic agents specifically to cancer cells, thereby improving drug bioavailability and reducing systemic toxicity. The project begins with an extensive literature review to explore the current landscape of drug delivery systems in cancer therapy. Various types of drug carriers, including nanoparticles, liposomes, and micelles, are analyzed for their potential applications in targeted cancer treatment. The review highlights the importance of precise drug delivery to achieve optimal therapeutic outcomes and minimize side effects. In the research methodology chapter, the experimental approach for developing novel drug delivery systems is detailed. This includes the synthesis of drug carriers, encapsulation of anticancer drugs, in vitro and in vivo evaluation of drug release kinetics, cellular uptake studies, and assessment of cytotoxicity against cancer cells. The methodology integrates both chemical and biological techniques to ensure the effectiveness and safety of the developed drug delivery systems. Chapter four presents a comprehensive discussion of the research findings, including the characterization of the developed drug carriers, their drug release profiles, cellular uptake mechanisms, and anticancer efficacy. The results demonstrate the feasibility and potential benefits of the novel drug delivery systems in enhancing the selectivity and effectiveness of cancer treatment. Finally, the conclusion chapter provides a summary of the key findings and contributions of the thesis. The significance of the research in advancing targeted cancer therapy is emphasized, along with recommendations for future studies to further optimize and translate the developed drug delivery systems into clinical applications. Overall, this thesis aims to contribute to the ongoing efforts to improve cancer treatment outcomes through innovative drug delivery approaches tailored for targeted therapy.

Thesis Overview